These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35177990)

  • 41. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study.
    Hosia-Randell HM; Muurinen SM; Pitkälä KH
    Drugs Aging; 2008; 25(8):683-92. PubMed ID: 18665660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C; Prado N; Acurcio F
    Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.
    Lao CK; Ho SC; Chan KK; Tou CF; Tong HH; Chan A
    Int J Clin Pharm; 2013 Oct; 35(5):805-12. PubMed ID: 23812679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
    Guastaldi RB; Reis AM; Figueras A; Secoli SR
    Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
    Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
    J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of Clinically Significant Drug-Drug Interactions Across US Children's Hospitals.
    Antoon JW; Hall M; Herndon A; Carroll A; Ngo ML; Freundlich KL; Stassun JC; Frost P; Johnson DP; Chokshi SB; Brown CM; Browning WL; Feinstein JA; Grijalva CG; Williams DJ
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33037121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.
    Jamani R; Lee EK; Berry SR; Saluja R; DeAngelis C; Giotis A; Emmenegger U
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1391-1399. PubMed ID: 27561266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentially inappropriate medications involved in drug-drug interactions at hospital discharge in Croatia.
    Marinović I; Bačić Vrca V; Samardžić I; Marušić S; Grgurević I
    Int J Clin Pharm; 2021 Jun; 43(3):566-576. PubMed ID: 33001315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, Uganda.
    Luzze B; Atwiine B; Lugobe HM; Yadesa TM
    BMC Cancer; 2022 Dec; 22(1):1266. PubMed ID: 36471270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians.
    Chan A; Yap KY; Koh D; Low XH; Cheung YT;
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):939-47. PubMed ID: 21732473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of comedications and potential drug-drug interactions in people living with HIV in China.
    Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
    J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study.
    Očovská Z; Maříková M; Vlček J
    Front Pharmacol; 2023; 14():1088900. PubMed ID: 36817138
    [No Abstract]   [Full Text] [Related]  

  • 54. Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study.
    Piccoliori G; Mahlknecht A; Sandri M; Valentini M; Vögele A; Schmid S; Deflorian F; Engl A; Sönnichsen A; Wiedermann C
    BMC Geriatr; 2021 Mar; 21(1):197. PubMed ID: 33743582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.
    Höner Zu Siederdissen C; Maasoumy B; Marra F; Deterding K; Port K; Manns MP; Cornberg M; Back D; Wedemeyer H
    Clin Infect Dis; 2016 Mar; 62(5):561-7. PubMed ID: 26611779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy.
    Ramos-Ruperez E; Escudero-Vilaplana V; Ruiz-Briones P; Collado-Borrell R; Villanueva-Bueno C; Revuelta-Herrero JL; González-Haba E; Garcia-Gonzalez X; Ibañez-Garcia S; Perez-Ramirez S; Zatarain-Nicolás E; Herranz A; Sanjurjo M
    Front Oncol; 2023; 13():1220305. PubMed ID: 37692846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
    Jazbar J; Locatelli I; Horvat N; Kos M
    Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients.
    Khan Q; Ismail M; Haider I; Ali Z
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):109-115. PubMed ID: 29458991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.